The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma Article Swipe
Kenji Nozaki
,
Dai Maruyama
,
Akiko Miyagi Maeshima
,
Kinuko Tajima
,
Jun Itami
,
Takafumi Shichijo
,
Sayako Yuda
,
Tomotaka Suzuki
,
Kosuke Toyoda
,
Nobuhiko Yamauchi
,
Shinichi Makita
,
Suguru Fukuhara
,
Wataru Munakata
,
Yukio Kobayashi
,
Hirokazu Taniguchi
,
Koji Izutsu
,
Kensei Tobinai
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1111/ejh.13539
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1111/ejh.13539
Objectives This study aimed to evaluate the outcomes of local radiotherapy (LRT) in patients with histologic transformation (HT) following rituximab‐containing chemotherapy. Methods We retrospectively analysed 92 patients with biopsy‐confirmed HT undergoing rituximab‐containing chemotherapy at our institution between 2003 and 2015. Results Of the 36 patients with limited‐stage disease at diagnosis of HT, 29 (78%) received LRT. The estimated 5‐year progression‐free survival (PFS) rate was significantly better in patients who underwent LRT than in those who did not (93% and 42%, respectively; P < 0.05). Multivariate analyses employing age, sex, performance status, LRT and treatment response demonstrated that LRT was an independent prognostic factor for PFS (hazard ratio [HR]: 11.8; 95% confidence interval [CI]: 1.28‐108.1; P < 0.05). Of the 32 patients who underwent LRT for HT lesion treatment, 31 (97%) did not show disease progression within radiation fields; among them, 27 patients (84%) survived without disease progression during the follow‐up period. One patient developed hypothyroidism due to LRT; the others had no acute or late‐onset complications of LRT. Conclusions Our data support the recommendation of LRT for HT lesion treatment following rituximab‐containing chemotherapy in select patients with localised HT, as a rational treatment approach with potentially limited toxicity.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1111/ejh.13539
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539
- OA Status
- hybrid
- References
- 17
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3093620604
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3093620604Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/ejh.13539Digital Object Identifier
- Title
-
The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-10-24Full publication date if available
- Authors
-
Kenji Nozaki, Dai Maruyama, Akiko Miyagi Maeshima, Kinuko Tajima, Jun Itami, Takafumi Shichijo, Sayako Yuda, Tomotaka Suzuki, Kosuke Toyoda, Nobuhiko Yamauchi, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Yukio Kobayashi, Hirokazu Taniguchi, Koji Izutsu, Kensei TobinaiList of authors in order
- Landing page
-
https://doi.org/10.1111/ejh.13539Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539Direct OA link when available
- Concepts
-
Medicine, Rituximab, Internal medicine, Hazard ratio, Chemotherapy, Oncology, Gastroenterology, Confidence interval, Radiation therapy, Stage (stratigraphy), Lymphoma, Surgery, Biology, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
17Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3093620604 |
|---|---|
| doi | https://doi.org/10.1111/ejh.13539 |
| ids.doi | https://doi.org/10.1111/ejh.13539 |
| ids.mag | 3093620604 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33098704 |
| ids.openalex | https://openalex.org/W3093620604 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000368 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Aged |
| mesh[1].qualifier_ui | Q000009 |
| mesh[1].descriptor_ui | D000971 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | adverse effects |
| mesh[1].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000971 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D059248 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Chemoradiotherapy |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003131 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Combined Modality Therapy |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | Q000175 |
| mesh[6].descriptor_ui | D016393 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | diagnosis |
| mesh[6].descriptor_name | Lymphoma, B-Cell |
| mesh[7].qualifier_ui | Q000401 |
| mesh[7].descriptor_ui | D016393 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | mortality |
| mesh[7].descriptor_name | Lymphoma, B-Cell |
| mesh[8].qualifier_ui | Q000628 |
| mesh[8].descriptor_ui | D016393 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapy |
| mesh[8].descriptor_name | Lymphoma, B-Cell |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D060787 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Neoplasm Grading |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D009367 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Neoplasm Staging |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000072078 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Positron Emission Tomography Computed Tomography |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D011379 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Prognosis |
| mesh[14].qualifier_ui | Q000379 |
| mesh[14].descriptor_ui | D018714 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | methods |
| mesh[14].descriptor_name | Radiotherapy, Adjuvant |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D012189 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Retrospective Studies |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D000069283 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Rituximab |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D016896 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Treatment Outcome |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000368 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Aged |
| mesh[19].qualifier_ui | Q000009 |
| mesh[19].descriptor_ui | D000971 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | adverse effects |
| mesh[19].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D000971 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D059248 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Chemoradiotherapy |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D003131 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Combined Modality Therapy |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000175 |
| mesh[24].descriptor_ui | D016393 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | diagnosis |
| mesh[24].descriptor_name | Lymphoma, B-Cell |
| mesh[25].qualifier_ui | Q000401 |
| mesh[25].descriptor_ui | D016393 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | mortality |
| mesh[25].descriptor_name | Lymphoma, B-Cell |
| mesh[26].qualifier_ui | Q000628 |
| mesh[26].descriptor_ui | D016393 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | therapy |
| mesh[26].descriptor_name | Lymphoma, B-Cell |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008875 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Middle Aged |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D060787 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Neoplasm Grading |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D009367 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Neoplasm Staging |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000072078 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Positron Emission Tomography Computed Tomography |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D011379 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Prognosis |
| mesh[32].qualifier_ui | Q000379 |
| mesh[32].descriptor_ui | D018714 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | methods |
| mesh[32].descriptor_name | Radiotherapy, Adjuvant |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D012189 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Retrospective Studies |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D000069283 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | Rituximab |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D016896 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Treatment Outcome |
| type | article |
| title | The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma |
| awards[0].id | https://openalex.org/G4849954485 |
| awards[0].funder_id | https://openalex.org/F4320311405 |
| awards[0].display_name | |
| awards[0].funder_award_id | 17ck0106348h0001 |
| awards[0].funder_display_name | Japan Agency for Medical Research and Development |
| biblio.issue | 2 |
| biblio.volume | 106 |
| biblio.last_page | 220 |
| biblio.first_page | 213 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T12212 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9991999864578247 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | CNS Lymphoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10685 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9987000226974487 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Viral-associated cancers and disorders |
| funders[0].id | https://openalex.org/F4320311405 |
| funders[0].ror | https://ror.org/004rtk039 |
| funders[0].display_name | Japan Agency for Medical Research and Development |
| is_xpac | False |
| apc_list.value | 4220 |
| apc_list.currency | USD |
| apc_list.value_usd | 4220 |
| apc_paid.value | 4220 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4220 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8813215494155884 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780653079 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8036271929740906 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q412323 |
| concepts[1].display_name | Rituximab |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7089524269104004 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C207103383 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6350593566894531 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[3].display_name | Hazard ratio |
| concepts[4].id | https://openalex.org/C2776694085 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6142992973327637 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[4].display_name | Chemotherapy |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.568497896194458 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C90924648 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5003917217254639 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[6].display_name | Gastroenterology |
| concepts[7].id | https://openalex.org/C44249647 |
| concepts[7].level | 2 |
| concepts[7].score | 0.47093144059181213 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[7].display_name | Confidence interval |
| concepts[8].id | https://openalex.org/C509974204 |
| concepts[8].level | 2 |
| concepts[8].score | 0.46597835421562195 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[8].display_name | Radiation therapy |
| concepts[9].id | https://openalex.org/C146357865 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4553554058074951 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[9].display_name | Stage (stratigraphy) |
| concepts[10].id | https://openalex.org/C2779338263 |
| concepts[10].level | 2 |
| concepts[10].score | 0.43086376786231995 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[10].display_name | Lymphoma |
| concepts[11].id | https://openalex.org/C141071460 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3643920421600342 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[11].display_name | Surgery |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C151730666 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[13].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8813215494155884 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/rituximab |
| keywords[1].score | 0.8036271929740906 |
| keywords[1].display_name | Rituximab |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.7089524269104004 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/hazard-ratio |
| keywords[3].score | 0.6350593566894531 |
| keywords[3].display_name | Hazard ratio |
| keywords[4].id | https://openalex.org/keywords/chemotherapy |
| keywords[4].score | 0.6142992973327637 |
| keywords[4].display_name | Chemotherapy |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.568497896194458 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/gastroenterology |
| keywords[6].score | 0.5003917217254639 |
| keywords[6].display_name | Gastroenterology |
| keywords[7].id | https://openalex.org/keywords/confidence-interval |
| keywords[7].score | 0.47093144059181213 |
| keywords[7].display_name | Confidence interval |
| keywords[8].id | https://openalex.org/keywords/radiation-therapy |
| keywords[8].score | 0.46597835421562195 |
| keywords[8].display_name | Radiation therapy |
| keywords[9].id | https://openalex.org/keywords/stage |
| keywords[9].score | 0.4553554058074951 |
| keywords[9].display_name | Stage (stratigraphy) |
| keywords[10].id | https://openalex.org/keywords/lymphoma |
| keywords[10].score | 0.43086376786231995 |
| keywords[10].display_name | Lymphoma |
| keywords[11].id | https://openalex.org/keywords/surgery |
| keywords[11].score | 0.3643920421600342 |
| keywords[11].display_name | Surgery |
| language | en |
| locations[0].id | doi:10.1111/ejh.13539 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S159715054 |
| locations[0].source.issn | 0902-4441, 1600-0609 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0902-4441 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | European Journal Of Haematology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Journal of Haematology |
| locations[0].landing_page_url | https://doi.org/10.1111/ejh.13539 |
| locations[1].id | pmid:33098704 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | European journal of haematology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33098704 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7894292 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Eur J Haematol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7894292 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5008160209 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6208-1227 |
| authorships[0].author.display_name | Kenji Nozaki |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[0].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Tokyo National Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kenji Nozaki |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[1].author.id | https://openalex.org/A5037105339 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0654-6920 |
| authorships[1].author.display_name | Dai Maruyama |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[1].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Tokyo National Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Dai Maruyama |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[2].author.id | https://openalex.org/A5049768782 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7251-7920 |
| authorships[2].author.display_name | Akiko Miyagi Maeshima |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pathology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[2].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Tokyo National Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Akiko Miyagi Maeshima |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pathology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[3].author.id | https://openalex.org/A5075059650 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kinuko Tajima |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[3].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Tokyo National Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kinuko Tajima |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[4].author.id | https://openalex.org/A5003511480 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1579-7406 |
| authorships[4].author.display_name | Jun Itami |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[4].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Tokyo National Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jun Itami |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[5].author.id | https://openalex.org/A5039471118 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1272-3738 |
| authorships[5].author.display_name | Takafumi Shichijo |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[5].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Tokyo National Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Takafumi Shichijo |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[6].author.id | https://openalex.org/A5071558844 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-7580-6445 |
| authorships[6].author.display_name | Sayako Yuda |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[6].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Tokyo National Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sayako Yuda |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[7].author.id | https://openalex.org/A5039702055 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-5694-8501 |
| authorships[7].author.display_name | Tomotaka Suzuki |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[7].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Tokyo National Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tomotaka Suzuki |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[8].author.id | https://openalex.org/A5076377460 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8125-4528 |
| authorships[8].author.display_name | Kosuke Toyoda |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[8].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Tokyo National Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Kosuke Toyoda |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[9].author.id | https://openalex.org/A5020757111 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-9254-2488 |
| authorships[9].author.display_name | Nobuhiko Yamauchi |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[9].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Tokyo National Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Nobuhiko Yamauchi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[10].author.id | https://openalex.org/A5080282516 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-6609-8088 |
| authorships[10].author.display_name | Shinichi Makita |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[10].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Tokyo National Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Shinichi Makita |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[11].author.id | https://openalex.org/A5002395792 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2423-9978 |
| authorships[11].author.display_name | Suguru Fukuhara |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[11].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[11].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Tokyo National Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Suguru Fukuhara |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[12].author.id | https://openalex.org/A5090320088 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4679-0656 |
| authorships[12].author.display_name | Wataru Munakata |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[12].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[12].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Tokyo National Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Wataru Munakata |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[13].author.id | https://openalex.org/A5052874191 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-2378-7865 |
| authorships[13].author.display_name | Yukio Kobayashi |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[13].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[13].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | Tokyo National Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Yukio Kobayashi |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[14].author.id | https://openalex.org/A5060602384 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-7999-8456 |
| authorships[14].author.display_name | Hirokazu Taniguchi |
| authorships[14].countries | JP |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Pathology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[14].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[14].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[14].institutions[0].country_code | JP |
| authorships[14].institutions[0].display_name | Tokyo National Hospital |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Hirokazu Taniguchi |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Pathology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[15].author.id | https://openalex.org/A5027118202 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-9129-8057 |
| authorships[15].author.display_name | Koji Izutsu |
| authorships[15].countries | JP |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[15].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[15].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[15].institutions[0].country_code | JP |
| authorships[15].institutions[0].display_name | Tokyo National Hospital |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Koji Izutsu |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[16].author.id | https://openalex.org/A5036000764 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-7859-3227 |
| authorships[16].author.display_name | Kensei Tobinai |
| authorships[16].countries | JP |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210156366 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| authorships[16].institutions[0].id | https://openalex.org/I4210156366 |
| authorships[16].institutions[0].ror | https://ror.org/05asn5035 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210156366 |
| authorships[16].institutions[0].country_code | JP |
| authorships[16].institutions[0].display_name | Tokyo National Hospital |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Kensei Tobinai |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Hematology, National Cancer Center Hospital, Tokyo, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2411583971, https://openalex.org/W2781286807, https://openalex.org/W31297289, https://openalex.org/W3082504439, https://openalex.org/W2265981062, https://openalex.org/W4251119054, https://openalex.org/W152659163, https://openalex.org/W2029951657, https://openalex.org/W2154169709, https://openalex.org/W4378648248 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1111/ejh.13539 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S159715054 |
| best_oa_location.source.issn | 0902-4441, 1600-0609 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0902-4441 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | European Journal Of Haematology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Journal of Haematology |
| best_oa_location.landing_page_url | https://doi.org/10.1111/ejh.13539 |
| primary_location.id | doi:10.1111/ejh.13539 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S159715054 |
| primary_location.source.issn | 0902-4441, 1600-0609 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0902-4441 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | European Journal Of Haematology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejh.13539 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Journal of Haematology |
| primary_location.landing_page_url | https://doi.org/10.1111/ejh.13539 |
| publication_date | 2020-10-24 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W2239810334, https://openalex.org/W2116573634, https://openalex.org/W1964744337, https://openalex.org/W2130159340, https://openalex.org/W1777323899, https://openalex.org/W2129200400, https://openalex.org/W1974149344, https://openalex.org/W2108131857, https://openalex.org/W2048307075, https://openalex.org/W1592515282, https://openalex.org/W2121960517, https://openalex.org/W2136326451, https://openalex.org/W1945274657, https://openalex.org/W2948321946, https://openalex.org/W2007831818, https://openalex.org/W2123439935, https://openalex.org/W3047374137 |
| referenced_works_count | 17 |
| abstract_inverted_index.P | 82, 115 |
| abstract_inverted_index.a | 191 |
| abstract_inverted_index.27 | 141 |
| abstract_inverted_index.29 | 53 |
| abstract_inverted_index.31 | 129 |
| abstract_inverted_index.32 | 120 |
| abstract_inverted_index.36 | 44 |
| abstract_inverted_index.92 | 26 |
| abstract_inverted_index.HT | 30, 126, 178 |
| abstract_inverted_index.Of | 42, 118 |
| abstract_inverted_index.We | 23 |
| abstract_inverted_index.an | 100 |
| abstract_inverted_index.as | 190 |
| abstract_inverted_index.at | 34, 49 |
| abstract_inverted_index.in | 13, 67, 73, 184 |
| abstract_inverted_index.no | 162 |
| abstract_inverted_index.of | 9, 51, 167, 175 |
| abstract_inverted_index.or | 164 |
| abstract_inverted_index.to | 5, 157 |
| abstract_inverted_index.95% | 110 |
| abstract_inverted_index.HT, | 52, 189 |
| abstract_inverted_index.LRT | 71, 92, 98, 124, 176 |
| abstract_inverted_index.One | 152 |
| abstract_inverted_index.Our | 170 |
| abstract_inverted_index.PFS | 105 |
| abstract_inverted_index.The | 57 |
| abstract_inverted_index.and | 39, 79, 93 |
| abstract_inverted_index.did | 76, 131 |
| abstract_inverted_index.due | 156 |
| abstract_inverted_index.for | 104, 125, 177 |
| abstract_inverted_index.had | 161 |
| abstract_inverted_index.not | 77, 132 |
| abstract_inverted_index.our | 35 |
| abstract_inverted_index.the | 7, 43, 119, 149, 159, 173 |
| abstract_inverted_index.was | 64, 99 |
| abstract_inverted_index.who | 69, 75, 122 |
| abstract_inverted_index.< | 83, 116 |
| abstract_inverted_index.(93% | 78 |
| abstract_inverted_index.(HT) | 18 |
| abstract_inverted_index.2003 | 38 |
| abstract_inverted_index.42%, | 80 |
| abstract_inverted_index.LRT. | 56, 168 |
| abstract_inverted_index.LRT; | 158 |
| abstract_inverted_index.This | 2 |
| abstract_inverted_index.age, | 88 |
| abstract_inverted_index.data | 171 |
| abstract_inverted_index.rate | 63 |
| abstract_inverted_index.sex, | 89 |
| abstract_inverted_index.show | 133 |
| abstract_inverted_index.than | 72 |
| abstract_inverted_index.that | 97 |
| abstract_inverted_index.with | 15, 28, 46, 187, 195 |
| abstract_inverted_index.(78%) | 54 |
| abstract_inverted_index.(84%) | 143 |
| abstract_inverted_index.(97%) | 130 |
| abstract_inverted_index.(LRT) | 12 |
| abstract_inverted_index.(PFS) | 62 |
| abstract_inverted_index.11.8; | 109 |
| abstract_inverted_index.2015. | 40 |
| abstract_inverted_index.[CI]: | 113 |
| abstract_inverted_index.[HR]: | 108 |
| abstract_inverted_index.acute | 163 |
| abstract_inverted_index.aimed | 4 |
| abstract_inverted_index.among | 139 |
| abstract_inverted_index.local | 10 |
| abstract_inverted_index.ratio | 107 |
| abstract_inverted_index.study | 3 |
| abstract_inverted_index.them, | 140 |
| abstract_inverted_index.those | 74 |
| abstract_inverted_index.0.05). | 84, 117 |
| abstract_inverted_index.better | 66 |
| abstract_inverted_index.during | 148 |
| abstract_inverted_index.factor | 103 |
| abstract_inverted_index.lesion | 127, 179 |
| abstract_inverted_index.others | 160 |
| abstract_inverted_index.select | 185 |
| abstract_inverted_index.within | 136 |
| abstract_inverted_index.(hazard | 106 |
| abstract_inverted_index.Methods | 22 |
| abstract_inverted_index.Results | 41 |
| abstract_inverted_index.between | 37 |
| abstract_inverted_index.disease | 48, 134, 146 |
| abstract_inverted_index.fields; | 138 |
| abstract_inverted_index.limited | 197 |
| abstract_inverted_index.patient | 153 |
| abstract_inverted_index.period. | 151 |
| abstract_inverted_index.status, | 91 |
| abstract_inverted_index.support | 172 |
| abstract_inverted_index.without | 145 |
| abstract_inverted_index.5‐year | 59 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.analysed | 25 |
| abstract_inverted_index.analyses | 86 |
| abstract_inverted_index.approach | 194 |
| abstract_inverted_index.evaluate | 6 |
| abstract_inverted_index.interval | 112 |
| abstract_inverted_index.outcomes | 8 |
| abstract_inverted_index.patients | 14, 27, 45, 68, 121, 142, 186 |
| abstract_inverted_index.rational | 192 |
| abstract_inverted_index.received | 55 |
| abstract_inverted_index.response | 95 |
| abstract_inverted_index.survival | 61 |
| abstract_inverted_index.survived | 144 |
| abstract_inverted_index.developed | 154 |
| abstract_inverted_index.diagnosis | 50 |
| abstract_inverted_index.employing | 87 |
| abstract_inverted_index.estimated | 58 |
| abstract_inverted_index.following | 19, 181 |
| abstract_inverted_index.localised | 188 |
| abstract_inverted_index.radiation | 137 |
| abstract_inverted_index.toxicity. | 198 |
| abstract_inverted_index.treatment | 94, 180, 193 |
| abstract_inverted_index.underwent | 70, 123 |
| abstract_inverted_index.Objectives | 1 |
| abstract_inverted_index.confidence | 111 |
| abstract_inverted_index.histologic | 16 |
| abstract_inverted_index.prognostic | 102 |
| abstract_inverted_index.treatment, | 128 |
| abstract_inverted_index.undergoing | 31 |
| abstract_inverted_index.Conclusions | 169 |
| abstract_inverted_index.follow‐up | 150 |
| abstract_inverted_index.independent | 101 |
| abstract_inverted_index.institution | 36 |
| abstract_inverted_index.performance | 90 |
| abstract_inverted_index.potentially | 196 |
| abstract_inverted_index.progression | 135, 147 |
| abstract_inverted_index.Multivariate | 85 |
| abstract_inverted_index.chemotherapy | 33, 183 |
| abstract_inverted_index.demonstrated | 96 |
| abstract_inverted_index.late‐onset | 165 |
| abstract_inverted_index.radiotherapy | 11 |
| abstract_inverted_index.1.28‐108.1; | 114 |
| abstract_inverted_index.chemotherapy. | 21 |
| abstract_inverted_index.complications | 166 |
| abstract_inverted_index.respectively; | 81 |
| abstract_inverted_index.significantly | 65 |
| abstract_inverted_index.hypothyroidism | 155 |
| abstract_inverted_index.recommendation | 174 |
| abstract_inverted_index.transformation | 17 |
| abstract_inverted_index.limited‐stage | 47 |
| abstract_inverted_index.retrospectively | 24 |
| abstract_inverted_index.biopsy‐confirmed | 29 |
| abstract_inverted_index.progression‐free | 60 |
| abstract_inverted_index.rituximab‐containing | 20, 32, 182 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5037105339 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 17 |
| corresponding_institution_ids | https://openalex.org/I4210156366 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.800000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.16320706 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |